Injectable Microfiber Scaffold for Minimally Invasive Tissue Repair

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for soft tissue injuries and degeneration, such as Intervertebral Disk Degeneration (IVD) and osteoarthritis, lack effective methods for repairing tissue integrity and preventing further deterioration, with existing techniques like suturing, stem cell injections, and autologous Chondrocyte Implantation (ACI) showing limited clinical advantages and requiring invasive surgeries.

Innovation Solution

An injectable scaffold comprising unclad microfibers and a diluent solution, where microfibers are formed through a stretch-and-fold method, unclad, hydrated, and seeded with cells before being injected into tissue defects, allowing for minimally invasive repair and crosslinking to form a solid scaffold.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If surgical interventions like suturing and annuloplasty are used to repair soft tissue, then tissue integrity can be restored, but the procedures are invasive and fail to improve annular strength

Engineering Contradiction:
Improveannular strengthVSAvoidinvasiveness of procedure
Core Design Contradiction:
StrengthVSEase of operation

Solution Approach 1:

The invention uses microfibers as segmented building blocks that can be individually injected and assembled in situ to form a repaired tissue structure, avoiding the need for invasive surgical suturing while restoring tissue strength through distributed fiber reinforcement

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfiber scaffold acts as an intermediary material that bridges the defect area and provides a framework for tissue regeneration, allowing strength restoration without direct surgical intervention on the tissue itself

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If stem cells are injected into the nucleus pulposus to treat degenerative IVD, then cell therapy is provided, but annular strength is not improved

Engineering Contradiction:
Improvetissue regeneration capabilityVSAvoidannular strength
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The invention combines microfibers with stem cells to create a composite scaffold structure where the fibrous framework provides mechanical strength while the embedded cells provide regenerative capability, achieving both strength improvement and tissue regeneration simultaneously

Inventive Principle:
Principle #40Composite materials

3Ease of manufacture

If microfracture procedure is performed to allow stem cells to enter cartilage defect, then cartilage repair is initiated, but cartilage scar forms that is not as resilient as native hyaline cartilage

Engineering Contradiction:
Improvesingle stage procedureVSAvoidcartilage resilience
Core Design Contradiction:
Ease of manufactureVSStrength

Solution Approach 1:

The microfiber scaffold is prepared in advance with appropriate architecture and mechanical properties before injection, providing a pre-formed framework that guides proper cartilage regeneration and prevents scar tissue formation from the outset

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention changes the physical and chemical parameters of the repair environment by providing a controlled microfiber scaffold with specific pore sizes, stiffness, and surface properties that promote hyaline cartilage differentiation rather than fibrocartilage scar formation

Inventive Principle:
Principle #35Parameter changes

4Strength

If Autologous Chondrocyte Implantation is performed to fill cartilage defects with expanded chondrocytes, then healing tissue more like native hyaline cartilage is achieved, but the procedure requires invasive surgery and two stages

Engineering Contradiction:
Improvecartilage qualityVSAvoidnumber of surgical stages
Core Design Contradiction:
StrengthVSDevice complexity

Solution Approach 1:

The invention merges the cell preparation and scaffold implantation into a single injectable procedure, combining the benefits of ACI (high-quality hyaline cartilage regeneration) with the simplicity of a minimally invasive single-stage operation

Inventive Principle:
Principle #5Merging (Combining)

5Ease of operation

If injectable microfiber scaffold is used for tissue repair, then minimally invasive repair is achieved, but the scaffold must be crosslinking to form solid structure

Engineering Contradiction:
Improveminimally invasive injectionVSAvoidcrosslinking process requirement
Core Design Contradiction:
Ease of operationVSDevice complexity

Solution Approach 1:

The microfiber scaffold utilizes phase transition of the crosslinking agent (from liquid to solid or from active to inactive state) to transform the injectable suspension into a solid, load-bearing structure after injection, enabling minimally invasive delivery followed by in situ structure formation

Inventive Principle:
Principle #36Phase transitions

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The scaffold enables effective tissue repair by promoting chondrogenesis, enhancing cartilage matrix deposition, and improving mechanical properties, with the ability to integrate with surrounding tissue, offering a less invasive and more effective alternative to existing methods.

Implementation Method 1

dissolving the cladding from the chips by contacting the chips with the uncladding solution to unclad the microfibers

Methodology Applied
Scientific EffectSolvation: Solvation

Implementation Method 2

hydrating the uncladded microfibers with a hydrating solution, thereby forming a paste

Methodology Applied
Scientific EffectAbsorption: Absorption (physical)

Implementation Method 3

crosslinking to form a solid scaffold

Methodology Applied
Scientific EffectCrosslinking: Chemical Bonding

Data Source

PatentUS20240033401A1Injectable, cross-linkable and subcellular size microfibers for soft tissue repair
Publication Date: 2024.02.01 THE CHILDRENS HOSPITAL OF PHILADELPHIA
  • US20240033401A1 patent drawing
  • US20240033401A1 patent drawing
  • US20240033401A1 patent drawing

AI summary

The present invention provides an injectable scaffold comprising a plurality of unclad microfibers, and a diluent solution.